Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Profit After Tax

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Profit After Tax History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit After Tax ₹1,310 Cr₹1,453 Cr₹129 Cr₹10,561 Cr₹610 Cr

What is the latest Profit After Tax of MANKIND PHARMA ?

The latest Profit After Tax ratio of MANKIND PHARMA is ₹1,310 Cr based on Mar2024 Consolidated results.
Year Profit After Tax
Mar2024₹1,310 Cr
Mar2023₹1,453 Cr
Mar2022₹129 Cr
Mar2021₹10,561 Cr
Mar2020₹610 Cr

How is Profit After Tax of MANKIND PHARMA Trending?

Years Profit After Tax % Change
Mar2024 ₹1,310 Cr
-9.86
Mar2023 ₹1,453 Cr
1,023.68
Mar2022 ₹129 Cr
-98.78
Mar2021 ₹10,561 Cr
1,630.02
Mar2020 ₹610 Cr -

Compare Profit After Tax of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,894.0 Cr -4.4% -7.8% 13.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,003.0 Cr -1.6% -4.6% 14.7% Stock Analytics
DIVIS LABORATORIES ₹154,939.0 Cr -1.6% -1.3% 61.6% Stock Analytics
CIPLA ₹117,835.0 Cr 0.1% 1.2% 3.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,787.0 Cr -2.1% -8.7% -2.3% Stock Analytics
ZYDUS LIFESCIENCES ₹90,722.1 Cr -6.5% -9.3% 8.6% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-4.4%

-7.8%

13.3%

SENSEX

-2.5%

-1.4%

6.1%


You may also like the below Video Courses